Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?
Alimentary Pharmacology & Therapeutics · 2023-04 · 57 (8) · 851-860
DOI: 10.1111/apt.17414 ↗At a glance
Übersichtsarbeit in Alimentary Pharmacology & Therapeutics, 2023-03. Written by B W L C M Broeders and 8 co-authors. Institution: Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium. Major MEDLINE topics: Dyspepsia, Duodenal Diseases, Eosinophilia. Cited 38 times so far (Crossref); 98 references.
Abstract (original language)
Background
Functional dyspepsia (FD) is one of the most frequent conditions in gastroenterological outpatient health care. Most recent research in FD has shifted its focus to duodenal pathophysiological mechanisms, although current treatments still focus mainly the stomach.
Aim
The aim of the study was to provide a comprehensive overview of the pathophysiology of FD focusing on a paradigm shift from gastric towards duodenal mechanisms.
Methods
We conducted a literature search in PubMed for studies describing mechanisms that could possibly cause FD.
Results
The pathophysiology of FD remains incompletely understood. Recent studies show that duodenal factors such as acid, bile salt exposure and eosinophil and mast cell activation correlate with symptom pattern and burden and can be associated with gastric sensorimotor dysfunction. The evolving data identify the duodenum an interesting target for new therapeutic approaches. Furthermore, the current first‐line treatment, that is proton pump inhibitors, reduces duodenal low‐grade inflammation and FD symptoms.
Conclusion
Future research for the treatment of FD should focus on the inhibition of duodenal mast cell activation, eosinophilia and loss of mucosal integrity.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
- Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
ORCID profiles: B W L C M Broeders, K Raymenants, T Vanuytsel, J Tack
Cite
APA
Broeders, B. W. L. C. M., Carbone, F., Balsiger, L. M., Schol, J., Raymenants, K., Huang, I., Verheyden, A., Vanuytsel, T., & Tack, J. (2023). Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?. Alimentary Pharmacology & Therapeutics, 57(8), 851-860. https://doi.org/10.1111/apt.17414
Vancouver
Broeders BWLCM, Carbone F, Balsiger LM, Schol J, Raymenants K, Huang I, et al. Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?. Alimentary Pharmacology & Therapeutics. 2023;57(8):851-860. doi:10.1111/apt.17414
BibTeX
@article{Broeders2023,
author = {Broeders, B W L C M and Carbone, F and Balsiger, L M and Schol, J and Raymenants, K and Huang, I and Verheyden, A and Vanuytsel, T and Tack, J},
title = {Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
volume = {57},
number = {8},
pages = {851--860},
doi = {10.1111/apt.17414}
}
EUVIMED